{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:55:34Z","timestamp":1794545734644,"version":"4.9.1"},"reference-count":65,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["2180 #390900677"],"award-info":[{"award-number":["2180 #390900677"]}]},{"name":"Deutsche Forschungsgemeinschaft (DFG)","award":["2064\/1 #390727645"],"award-info":[{"award-number":["2064\/1 #390727645"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Besides tremendous treatment success in advanced melanoma patients, the rapid development of oncologic treatment options comes with increasingly high costs and can cause severe life-threatening side effects. For this purpose, predictive baseline biomarkers are becoming increasingly important for risk stratification and personalized treatment planning. Thus, the aim of this pilot study was the development of a prognostic tool for the risk stratification of the treatment response and mortality based on PET\/MRI and PET\/CT, including a convolutional neural network (CNN) for metastasized-melanoma patients before systemic-treatment initiation. The evaluation was based on 37 patients (19 f, 62 \u00b1 13 y\/o) with unresectable metastasized melanomas who underwent whole-body 18F-FDG PET\/MRI and PET\/CT scans on the same day before the initiation of therapy with checkpoint inhibitors and\/or BRAF\/MEK inhibitors. The overall survival (OS), therapy response, metastatically involved organs, number of lesions, total lesion glycolysis, total metabolic tumor volume (TMTV), peak standardized uptake value (SULpeak), diameter (Dmlesion) and mean apparent diffusion coefficient (ADCmean) were assessed. For each marker, a Kaplan\u2013Meier analysis and the statistical significance (Wilcoxon test, paired t-test and Bonferroni correction) were assessed. Patients were divided into high- and low-risk groups depending on the OS and treatment response. The CNN segmentation and prediction utilized multimodality imaging data for a complementary in-depth risk analysis per patient. The following parameters correlated with longer OS: a TMTV &lt; 50 mL; no metastases in the brain, bone, liver, spleen or pleura; \u22644 affected organ regions; no metastases; a Dmlesion &gt; 37 mm or SULpeak &lt; 1.3; a range of the ADCmean &lt; 600 mm2\/s. However, none of the parameters correlated significantly with the stratification of the patients into the high- or low-risk groups. For the CNN, the sensitivity, specificity, PPV and accuracy were 92%, 96%, 92% and 95%, respectively. Imaging biomarkers such as the metastatic involvement of specific organs, a high tumor burden, the presence of at least one large lesion or a high range of intermetastatic diffusivity were negative predictors for the OS, but the identification of high-risk patients was not feasible with the handcrafted parameters. In contrast, the proposed CNN supplied risk stratification with high specificity and sensitivity.<\/jats:p>","DOI":"10.3390\/diagnostics12092102","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T21:25:18Z","timestamp":1661894718000},"page":"2102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET\/CT and PET\/MRI Data"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-4898","authenticated-orcid":false,"given":"Thomas","family":"K\u00fcstner","sequence":"first","affiliation":[{"name":"MIDAS.Lab, Department of Radiology, University Hospital of T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-7234","authenticated-orcid":false,"given":"Jonas","family":"Vogel","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University Hospital T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hepp","sequence":"additional","affiliation":[{"name":"MIDAS.Lab, Department of Radiology, University Hospital of T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-4945","authenticated-orcid":false,"given":"Andrea","family":"Forschner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital of T\u00fcbingen, 72070 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pfannenberg","sequence":"additional","affiliation":[{"name":"Department of Radiology, Diagnostic and Interventional Radiology, University Hospital of T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Eberhard-Karls-University T\u00fcbingen, 72076 Tubingen, Germany"},{"name":"Siemens Healthineers, 91052 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9091-2190","authenticated-orcid":false,"given":"Nina F.","family":"Schwenzer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Eberhard-Karls-University T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-7325","authenticated-orcid":false,"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Diagnostic and Interventional Radiology, University Hospital of T\u00fcbingen, 72076 Tubingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, 72076 Tubingen, Germany"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University Hospital T\u00fcbingen, 72076 Tubingen, Germany"},{"name":"Cluster of Excellence iFIT (EXC 2180) Image-Guided and Functionally Instructed Tumor Therapies, Eberhard Karls University, 72076 Tubingen, Germany"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Seith","sequence":"additional","affiliation":[{"name":"Department of Radiology, Diagnostic and Interventional Radiology, University Hospital of T\u00fcbingen, 72076 Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1200\/JCO.2018.36.15_suppl.9516","article-title":"5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001","volume":"36","author":"Hamid","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2017.74.1025","article-title":"Long-Term Outcomes in Patients With BRAF V600\u2013Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib","volume":"36","author":"Long","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Filippi, L., Bianconi, F., Schillaci, O., Spanu, A., and Palumbo, B. (2022). The Role and Potential of (18)F-FDG PET\/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040929"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rivas, A., Delyon, J., Martineau, A., Blanc, E., Allayous, C., Da Meda, L., Merlet, P., Lebbe, C., Baroudjian, B., and Vercellino, L. (2022). 18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors. Cancers, 14.","DOI":"10.3390\/cancers14133190"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-017-3813-2","article-title":"18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start","volume":"45","author":"Seith","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40644-020-00313-2","article-title":"(18)F-FDG PET\/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma","volume":"20","author":"Wong","year":"2020","journal-title":"Cancer Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kudura, K., Dimitriou, F., Basler, L., Forster, R., Mihic-Probst, D., Kutzker, T., Dummer, R., Mangana, J., Burger, I.A., and Kreissl, M.C. (2021). Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET\/CT in Melanoma Patients. Cancers, 13.","DOI":"10.3390\/cancers13153830"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.tranon.2017.09.007","article-title":"Intratumor and Intertumor Heterogeneity in Melanoma","volume":"10","author":"Grzywa","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra1204892","article-title":"The implications of clonal genome evolution for cancer medicine","volume":"368","author":"Aparicio","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1038\/s41598-019-41098-0","article-title":"Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/S2589-7500(20)30160-6","article-title":"Artificial intelligence in medical imaging: Switching from radiographic pathological data to clinically meaningful endpoints","volume":"2","author":"Oren","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: Images Are More than Pictures, They Are Data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dildar, M., Akram, S., Irfan, M., Khan, H.U., Ramzan, M., Mahmood, A.R., Alsaiari, S.A., Saeed, A.H.M., Alraddadi, M.O., and Mahnashi, M.H. (2021). Skin Cancer Detection: A Review Using Deep Learning Techniques. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18105479"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2018.08.032","article-title":"A Deep Look Into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change","volume":"102","author":"Morin","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/1078-0432.CCR-18-0385","article-title":"Data Analysis Strategies in Medical Imaging","volume":"24","author":"Parmar","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9512370","DOI":"10.1155\/2017\/9512370","article-title":"Application of Deep Learning in Automated Analysis of Molecular Images in Cancer: A Survey","volume":"2017","author":"Xue","year":"2017","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.media.2016.10.004","article-title":"Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation","volume":"36","author":"Kamnitsas","year":"2017","journal-title":"Med. Image Anal."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ghafoorian, M., Karssemeijer, N., Heskes, T., van Uder, I.W.M., de Leeuw, F.E., Marchiori, E., van Ginneken, B., and Platel, B. (2016, January 13\u201316). Non-uniform patch sampling with deep convolutional neural networks for white matter hyperintensity segmentation. Proceedings of the 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI), Prague, Czech Republic.","DOI":"10.1109\/ISBI.2016.7493532"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1109\/TMI.2016.2528821","article-title":"Deep 3D Convolutional Encoder Networks With Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation","volume":"35","author":"Brosch","year":"2016","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1109\/TMI.2016.2536809","article-title":"Pulmonary Nodule Detection in CT Images: False Positive Reduction Using Multi-View Convolutional Networks","volume":"35","author":"Setio","year":"2016","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_23","unstructured":"Kawahara, J., and Hamarneh, G. Multi-Resolution-Tract CNN with Hybrid Pretrained and Skin-Lesion Trained Layers, Spring."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/ai3020029","article-title":"Automatic Classification of Melanoma Skin Cancer with Deep Convolutional Neural Networks","volume":"3","author":"Aljohani","year":"2022","journal-title":"Ai"},{"key":"ref_25","first-page":"305","article-title":"Deep learning based imaging data completion for improved brain disease diagnosis","volume":"17","author":"Li","year":"2014","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1109\/TMI.2016.2535865","article-title":"Lung Pattern Classification for Interstitial Lung Diseases Using a Deep Convolutional Neural Network","volume":"35","author":"Anthimopoulos","year":"2016","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_27","unstructured":"Fakoor, R., Ladhak, F., Nazi, A., and Huber, M. (2013, January 16\u201321). Using deep learning to enhance cancer diagnosis and classification. Proceedings of the International Conference on Machine Learning, Atlanta, GA, USA."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5:1","DOI":"10.1147\/JRD.2017.2708299","article-title":"Deep learning ensembles for melanoma recognition in dermoscopy images","volume":"61","author":"Codella","year":"2017","journal-title":"IBM J. Res. Dev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1109\/TMI.2016.2642839","article-title":"Automated Melanoma Recognition in Dermoscopy Images via Very Deep Residual Networks","volume":"36","author":"Yu","year":"2017","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s11548-017-1567-8","article-title":"Extraction of skin lesions from non-dermoscopic images for surgical excision of melanoma","volume":"12","author":"Jafari","year":"2017","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Nasr-Esfahani, E., Samavi, S., Karimi, N., Soroushmehr, S.M.R., Jafari, M.H., Ward, K., and Najarian, K. (2016, January 16\u201320). Melanoma detection by analysis of clinical images using convolutional neural network. Proceedings of the 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA.","DOI":"10.1109\/EMBC.2016.7590963"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106902","DOI":"10.1016\/j.cmpb.2022.106902","article-title":"Computer-aided detection and segmentation of malignant melanoma lesions on whole-body (18)F-FDG PET\/CT using an interpretable deep learning approach","volume":"221","author":"Dirks","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cire\u015fan, D.C., Giusti, A., Gambardella, L.M., and Schmidhuber, J. (2013). Mitosis Detection in Breast Cancer Histology Images with Deep Neural Networks, Springer.","DOI":"10.1007\/978-3-642-40763-5_51"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"034003","DOI":"10.1117\/1.JMI.1.3.034003","article-title":"Mitosis detection in breast cancer pathology images by combining handcrafted and convolutional neural network features","volume":"1","author":"Wang","year":"2014","journal-title":"J. Med. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cruz-Roa, A., Basavanhally, A., Gonz\u00e1lez, F., Gilmore, H., Feldman, M., Ganesan, S., Shih, N., Tomaszewski, J., and Madabhushi, A. (2014, January 15\u201320). Automatic detection of invasive ductal carcinoma in whole slide images with convolutional neural networks. Proceedings of the Medical Imaging 2014: Digital Pathology, San Diego, CA, USA.","DOI":"10.1117\/12.2043872"},{"key":"ref_37","first-page":"520","article-title":"A new 2.5D representation for lymph node detection using random sets of deep convolutional neural network observations","volume":"17","author":"Roth","year":"2014","journal-title":"MICCAI Int. Conf. Med. Image Comput. Comput. Assist. Interv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1109\/TMI.2016.2528162","article-title":"Deep convolutional neural networks for computer-aided detection: CNN architectures, dataset characteristics and transfer learning","volume":"35","author":"Shin","year":"2016","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/21681163.2016.1138240","article-title":"An analysis of robust cost functions for CNN in computer-aided diagnosis","volume":"6","author":"Barbu","year":"2018","journal-title":"Comput. Methods Biomech. Biomed. Eng. Imaging Vis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1109\/TMI.2015.2482920","article-title":"Improving computer-aided detection using convolutional neural networks and random view aggregation","volume":"35","author":"Roth","year":"2015","journal-title":"IEEE Trans. Med. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/STROKEAHA.117.019740","article-title":"Prediction of Tissue Outcome and Assessment of Treatment Effect in Acute Ischemic Stroke Using Deep Learning","volume":"49","author":"Nielsen","year":"2018","journal-title":"Stroke"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/mp.12967","article-title":"Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers","volume":"45","author":"Deist","year":"2018","journal-title":"Med. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jojoa Acosta, M.F., Caballero Tovar, L.Y., Garcia-Zapirain, M.B., and Percybrooks, W.S. (2021). Melanoma diagnosis using deep learning techniques on dermatoscopic images. BMC Med. Imaging, 21.","DOI":"10.1186\/s12880-020-00534-8"},{"key":"ref_44","first-page":"212","article-title":"3D Deep Learning for Multi-modal Imaging-Guided Survival Time Prediction of Brain Tumor Patients","volume":"9901","author":"Nie","year":"2016","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1038\/s41598-018-21758-3","article-title":"Deep learning based tissue analysis predicts outcome in colorectal cancer","volume":"8","author":"Bychkov","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00259-017-3898-7","article-title":"Prediction of outcome using pretreatment (18)F-FDG PET\/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy","volume":"45","author":"Lucia","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e000656","DOI":"10.1136\/jitc-2020-000656","article-title":"Is there a link between very early changes of primary and secondary lymphoid organs in (18)F-FDG-PET\/MRI and treatment response to checkpoint inhibitor therapy?","volume":"8","author":"Seith","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_48","unstructured":"Nicholson, T. (2014). Imaging in the evaluation of cancer. Recommendations for Cross-Sectional Imaging in Cancer Management, The Royal College of Radiologists. [2nd ed.]."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-014-2705-y","article-title":"Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients","volume":"41","author":"Meignan","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00259-020-04757-3","article-title":"Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4","volume":"47","author":"Seban","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zagoruyko, S., and Komodakis, N. (2016). Wide residual networks. arXiv.","DOI":"10.5244\/C.30.87"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/RTI.0000000000000522","article-title":"Fully Automated Segmentation and Shape Analysis of the Thoracic Aorta in Non-contrast-enhanced Magnetic Resonance Images of the German National Cohort Study","volume":"35","author":"Hepp","year":"2020","journal-title":"J. Thorac. Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical Care Costs Associated with Cancer Survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of Immune-Related Adverse Events and Kinetics of Response with Ipilimumab","volume":"30","author":"Weber","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: A systematic review and meta-analysis","volume":"55","author":"Pak","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1097\/RLU.0000000000001205","article-title":"Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET\/CT in Patients With Cutaneous Malignant Melanoma","volume":"41","author":"Son","year":"2016","journal-title":"Clin. Nucl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.32522","article-title":"Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy","volume":"126","author":"Lo","year":"2020","journal-title":"Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00259-018-4211-0","article-title":"Prognostic value of baseline metabolic tumor volume measured on (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in melanoma patients treated with ipilimumab therapy","volume":"46","author":"Ito","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hlongwa, K.N., Mokoala, K.M.G., Matsena-Zingoni, Z., Vorster, M., and Sathekge, M.M. (2022). The Use of (18)F-FDG PET\/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030595"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"16832","DOI":"10.18632\/oncotarget.24709","article-title":"Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas","volume":"9","author":"Acciardo","year":"2018","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bilen, M.A., Shabto, J.M., Martini, D.J., Liu, Y., Lewis, C., Collins, H., Akce, M., Kissick, H., Carthon, B.C., and Shaib, W.L. (2019). Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6073-7"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1754-1611-8-12","article-title":"Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors","volume":"8","author":"Sefidgar","year":"2014","journal-title":"J. Biol. Eng."},{"key":"ref_64","first-page":"e90","article-title":"Prognostic Value of Low Tumor Burden in Patients With Melanoma","volume":"32","author":"Poklepovic","year":"2018","journal-title":"Oncology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u2018Immunoscore\u2019 in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J. Pathol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/9\/2102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:09Z","timestamp":1760142009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/9\/2102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["diagnostics12092102"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12092102","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}